How to buy Emergent BioSolutions shares | 11 March price $92.93

How to buy Emergent BioSolutions shares | $92.93

Own Emergent BioSolutions shares in just a few minutes. Share price changes are updated daily.

Emergent BioSolutions Inc (EBS) is a leading drug manufacturers-specialty and generic business based in the US. It opened the day at $91.79 after a previous close of $89.63. During the day the price has varied from a low of $91.46 to a high of $94.63. The latest price was $92.93 (25 minute delay). Emergent BioSolutions is listed on the NYSE and employs 2,200 staff. All prices are listed in US Dollars.

How to buy shares in Emergent BioSolutions

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: EBS in this case.
  5. Research Emergent BioSolutions shares. The platform should provide the latest information available.
  6. Buy your Emergent BioSolutions shares. It's that simple.
The whole process can take as little as 15 minutes.

Emergent BioSolutions share price

Use our graph to track the performance of EBS stocks over time.

Emergent BioSolutions shares at a glance

Information last updated 2021-03-11.
Previous close$89.63
Change $3.3
Change % 3.6818%
Volume 185,145
Information last updated 2021-04-15.
52-week range$64.04 - $137.61
50-day moving average $88.9089
200-day moving average $95.8325
Wall St. target price$113.86
PE ratio 13.2381
Dividend yield N/A (0%)
Earnings per share (TTM) $5.67
eToro Free Stocks

Invest in Emergent BioSolutions shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Fees for buying 10x Emergent BioSolutions shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Fineco logo £0 No minimum £9.50
£674.04 total
Capital at risk
eToro Free Stocks logo £0 $200 £3.32
£667.87 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.12
£665.67 total
Capital at risk
Stake logo £0 £50 £3.35
£667.89 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £18.62
£683.17 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £17.99
£682.53 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £17.84
£682.38 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Emergent BioSolutions stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Emergent BioSolutions price performance over time

Historical closes compared with the last close of $92.93

1 week (2021-04-13) 27.72%
1 month (2021-03-19) 2.14%
3 months (2021-01-20) -13.85%
6 months (2020-10-20) -3.91%
1 year (2020-04-20) 32.38%
2 years (2019-04-18) 75.47%
3 years (2018-04-20) 71.30%
5 years (2016-04-20) 152.30%

Is Emergent BioSolutions under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

Emergent BioSolutions's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Emergent BioSolutions shares trade at around 13x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

PEG ratio

Emergent BioSolutions's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.55. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Emergent BioSolutions's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.


Emergent BioSolutions's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $604.5 million (£0.0 million).

The EBITDA is a measure of a Emergent BioSolutions's overall financial performance and is widely used to measure a its profitability.


Revenue TTM $1.6 billion
Operating margin TTM 31.79%
Gross profit TTM $857.6 million
Return on assets TTM 11.86%
Return on equity TTM 24.07%
Profit margin 19.62%
Book value $27.25
Market capitalisation $4 billion

TTM: trailing 12 months

How to short and sell Emergent BioSolutions shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "EBS.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 2.6 million Emergent BioSolutions shares held short by investors – that's known as the "short interest". This figure is 4.6% up from 2.5 million last month.

There are a few different ways that this level of interest in shorting Emergent BioSolutions shares can be evaluated.

Short interest ratio (SIR)

Emergent BioSolutions's "short interest ratio" (SIR) is the quantity of Emergent BioSolutions shares currently shorted divided by the average quantity of Emergent BioSolutions shares traded daily (recently around 597401.6091954). Emergent BioSolutions's SIR currently stands at 4.35. In other words for every 100,000 Emergent BioSolutions shares traded daily on the market, roughly 4350 shares are currently held short.

However Emergent BioSolutions's short interest can also be evaluated against the total number of Emergent BioSolutions shares, or, against the total number of tradable Emergent BioSolutions shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Emergent BioSolutions's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Emergent BioSolutions shares in existence, roughly 50 shares are currently held short) or 0.0602% of the tradable shares (for every 100,000 tradable Emergent BioSolutions shares, roughly 60 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Emergent BioSolutions.

Find out more about how you can short Emergent BioSolutions stock.

Emergent BioSolutions share dividends

We're not expecting Emergent BioSolutions to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Emergent BioSolutions's shares have ranged in value from as little as $64.04 up to $137.61. A popular way to gauge a stock's volatility is its "beta".

EBS.US volatility(beta: 1.17)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Emergent BioSolutions's is 1.1655. This would suggest that Emergent BioSolutions's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site